Open·Ingested 45 days ago, not re-verified since

DoW Neurofibromatosis Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: Jun 25, 2026
Amount: $6,040,000
Closes: Sep 22, 2026 (in 43 days)

Similar opportunities open now

DoW Neurofibromatosis Exploration-Hypothesis Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 43 days
DoW Multiple Sclerosis Investigator-Initiated Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 3 days
DoW Spinal Cord Injury, Investigator-Initiated Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW, Ovarian Cancer, Investigator-Initiated Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 52 days
DoW Multiple Sclerosis Early Investigator Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 3 days

Classification and identifiers

Solicitation number: HT942526NFRPIIRA
Assistance listing (CFDA): 12.420

Amount

$6,040,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project. Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features: • Open...